Metrics as of 10/17/2026, 03:34 AM (Berlin time), refresh in progress.
Hikma Pharmaceuticals Stock
Hikma Pharmaceuticals PLC
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United Kingdom
- CEO
- Said Samih Taleb Darwazah
- Employees
- 9,500
- Market cap
- £3.4 B
- IPO
- 01/11/2005
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms.…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Hikma Pharmaceuticals stock: price history
1D
+1.2%
1W
+3.1%
1M
+6.2%
6M
+20.5%
YTD
+7.2%
1Y
-6.3%
2Y
-17.0%
5Y
-29.1%
10Y
-18.1%
Next earnings date
Next earnings date
25/02/2027 (in 131 days)
Volatility around earnings
~53% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Hikma Pharmaceuticals
Hikma Pharmaceuticals stock metrics
P/E
12.37
P/B
1.85
EV/EBITDA
7.07
RETURN ON EQUITY
8.7%
NET MARGIN
12.9%
DEBT/EQUITY
0.78
DIVIDEND YIELD
3.8%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
70.5%
FLOAT SHARES
145,965,408
AVG. DAILY VOLUME (30D)
485,215
Dividends
Comparable stocks
Frequently asked questions about Hikma Pharmaceuticals stock
What does Hikma Pharmaceuticals do?
Hikma Pharmaceuticals PLC is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United Kingdom.
The CEO is Said Samih Taleb Darwazah, the company employs around 9,500 people.
The IPO was on 01/11/2005; the stock trades on LSE under the ticker HIK.L.
When does Hikma Pharmaceuticals report next?
The next earnings date is 25/02/2027.
Around past earnings, price swings were roughly 53% stronger than usual.
Does Hikma Pharmaceuticals pay a dividend?
Yes. The last dividend was £28.14 per share, ex-date 13/08/2026, paid on 17/09/2026.
The dividend yield is 3.8% (as of 30/06/2026).
Which stocks are comparable to Hikma Pharmaceuticals?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Hikma Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Hikma Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.